INSIGHTS ON DRUG DEVELOPMENT
-
AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids
Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.
-
Doubling Up For Speed In Biomanufacturing
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
How To Confidently Predict Toxicity Of Preclinical Drug Candidates
Incorporating Liver-Chips into preclinical workflows could reduce drug-induced liver injury-related trial failures. Review this quantitative framework for integrating Liver-Chip data into pharmaceutical decision-making.
-
Addressing Raw Material Handling Challenges By Dry Granulation
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
Amorphous Stability: Mesoporous Silica For Poor Glass Formers6/5/2025
Discover how mesoporous silica outperforms polymeric solid dispersions in stabilizing poor glass formers, as well as how it offers a novel approach to enhance amorphous drug stability and bioavailability.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics11/6/2024
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Your AKTA Oligosynt™ System : It's More Than A Machine2/9/2026
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
-
Comprehensive GMP Testing Services3/31/2025
Eurofins delivers global GMP testing with 45+ facilities, ensuring regulatory acceptance, quality, and trusted service from starting materials to finished products.
-
Cost Modeling Analysis Of AAV And LV Manufacturing3/31/2026
Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.
DRUG DEVELOPMENT SOLUTIONS
-
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
DSC and ITC offer deep insights into molecular binding and structural stability, which help researchers uncover thermodynamic drivers and domain-level behavior essential for protein characterization.
-
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
In silico modeling technologies are transforming drug development and manufacturing by enhancing efficiency, accuracy, to allow innovations.
-
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.